Loading...
XJPX
7775
Market cap74mUSD
Jul 10, Last price  
422.00JPY
1D
0.48%
1Q
-6.01%
Jan 2017
-47.51%
IPO
160.49%
Name

Daiken Medical Co Ltd

Chart & Performance

D1W1MN
XJPX:7775 chart
P/E
13.14
P/S
1.18
EPS
32.12
Div Yield, %
5.24%
Shrs. gr., 5y
Rev. gr., 5y
5.53%
Revenues
10.29b
+3.41%
4,608,452,0005,181,784,0005,739,369,0006,242,357,0006,515,255,0007,068,350,0007,635,801,0008,033,054,0008,261,416,0008,399,605,0008,585,276,0008,406,607,0008,523,354,0007,861,969,0008,540,443,0009,137,102,0009,750,166,0009,951,701,00010,290,984,000
Net income
923m
-15.94%
317,373,000369,494,000487,503,000555,058,000404,108,000787,543,000881,497,0001,097,854,0001,153,281,0001,246,001,0001,012,144,000851,600,000859,547,000675,231,000831,056,000712,062,000988,602,0001,097,620,000922,641,000
CFO
568m
-49.35%
133,491,000613,181,000551,536,000920,778,000254,180,0001,211,669,000995,060,0001,140,020,0001,294,996,0001,350,353,0001,255,103,000880,925,0001,436,905,000609,170,0001,133,623,000989,156,0001,555,500,0001,120,908,000567,713,000
Dividend
Sep 29, 20269 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Daiken Medical Co., Ltd. is a global developer and provider of healthcare devices and equipment, serving both the Japanese market and international clientele. Its extensive product catalog includes syringe pumps, disposable and portable infusion pumps, endobronchial blocker tubes, a range of suction accessories (containers, connecting tubes, and tips), medical hand washing machines, disposable medical towels, sterilize mats, and wet disinfectant mats. Additionally, the company engages in the trade of other medical apparatus. All its offerings are marketed under the COOPDECH brand. Established in 1968, Daiken Medical Co., Ltd. maintains its headquarters in Izumi, Japan.
IPO date
Mar 12, 2009
Employees
188
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT